The Hong Kong Polytechnic University Featured PhD Programmes
Imperial College London Featured PhD Programmes
University College London Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Leeds Featured PhD Programmes
"action" AND "research"×
10 miles

Biochemistry (action research) PhD Projects, Programs & Scholarships

We have 60 Biochemistry (action research) PhD Projects, Programs & Scholarships

  • "action" AND "research" ×
  • Biochemistry×
  • clear all
Order by 
Showing 1 to 10 of 60
  Investigation of a probiotic strain of Lactobacillus plantarum 2025 and the development of novel antibacterials
  Prof A Karlyshev
Applications accepted all year round

Funding Type

PhD Type

Background. The rise of multidrug resistant forms of microbial pathogens imposes a serious problem to public health worldwide. The rapid spread of antimicrobial resistance is associated with misuse of conventional antibiotics.
  MRC DiMeN Doctoral Training Partnership: Bacteriolysis: how cell envelope-targeting antibiotics trick bacteria to self-digest
  Dr H Strahl von Schulten, Dr A Fenton
Application Deadline: 6 January 2020

Funding Type

PhD Type

The bacterial cell envelope is the target for some of our most successful antibiotics including penicillins and cephalosporins, and also for last-resort antibiotics such as vancomycin and daptomycin used to treat life-threatening multidrug-resistant bacterial infections.
  EASTBIO: Investigating the effect of underutilised, emerging, polyphenol-rich berries on cardiometabolic health.
  Dr N Hoggard, Dr V Rungapamestry, Dr G McDougall
Application Deadline: 5 January 2020

Funding Type

PhD Type

Supervisors. Dr Nigel Hoggard (University of Aberdeen). http://www.abdn.ac.uk/rowett/research/nigel-hoggard.php. Dr Vanessa Rungapamestry (University of Aberdeen).
  Inhibition of PRMT5 as a cancer therapy
  Dr K. Sheppard
Applications accepted all year round

Funding Type

PhD Type

Targeted therapy has had profound impact on outcomes for cancer patients.
  mRNA translation reprogramming and metabolic re-wiring in response to ribosome-targeted therapies
  Prof R. Pearson, Dr J Kang
Applications accepted all year round

Funding Type

PhD Type

Increased synthesis and activity of ribosomes are associated with oncogenesis downstream of the major oncogenes including MYC, RAS and PI3K.
  Identification of novel glucose-dependent alterations responsible for vascular dysfunction in Type 2 diabetes.
  Prof Tim Palmer, Dr R Sturmey
Application Deadline: 31 March 2020

Funding Type

PhD Type

Diabetes is a growing global healthcare problem. The majority of people living with diabetes have Type 2 diabetes mellitus (T2DM), characterised by a resistance of the body to the action of insulin.
  Measuring tuberculosis metabolism noninvasively to understand antibiotic action
  Dr J Blaza, Dr A Kennerley
Application Deadline: 8 January 2020

Funding Type

PhD Type

Background. Tuberculosis is a devastating disease caused by Mycobacterium tuberculosis and is one of the top 10 causes of death worldwide (World Health Organisation; 2016).
  China Scholarship Council - Chemical Structural Biology and Mechanistic Insights into PROTAC Mode of Action
  Prof A Ciulli, Prof D Alessi
Application Deadline: 15 January 2020

Funding Type

PhD Type

The School of Life Sciences at the University of Dundee, joint with the China Scholarship Council (CSC), is proud to be able to offer a scholarship programme for postgraduate research students.
  EASTBIO: Impact of steroid hormone environment on immune cell phenotype and function
  Prof I McEwan, Dr D Gibson, Prof H M Wilson
Application Deadline: 5 January 2020

Funding Type

PhD Type

Supervisors. Professor Iain J McEwan (University of Aberdeen). https://www.abdn.ac.uk/ims/research/profiles/iain.mcewan. Dr Douglas Gibson (University of Edinburgh).
  A multidisciplinary approach to target MYC-driven childhood cancers
  Prof E Tate, Prof L Chesler
Application Deadline: 22 November 2019

Funding Type

PhD Type

Synthetic lethality driven by N-myristoyltransferase inhibition. a convergence approach to target MYCN-driven childhood cancers. Short title.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.